Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice.
about
Prospects for gene transfer for clinical heart failureImpaired water reabsorption in mice deficient in the type VI adenylyl cyclase (AC6)Reduced collagen deposition in infarcted myocardium facilitates induced pluripotent stem cell engraftment and angiomyogenesis for improvement of left ventricular function.Cardiac-Directed Expression of Adenylyl Cyclase Catalytic Domain Reverses Cardiac Dysfunction Caused by Sustained Beta-Adrenergic Receptor Stimulation.Gene expression and β-adrenergic signaling are altered in hypoplastic left heart syndrome.Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload.Phosphoprotein abundance changes in hypertensive cardiac remodeling.Beneficial effects of adenylyl cyclase type 6 (AC6) expression persist using a catalytically inactive AC6 mutant.Adenylyl cyclase 6 deletion reduces left ventricular hypertrophy, dilation, dysfunction, and fibrosis in pressure-overloaded female mice.Adenylyl cyclase 6 improves calcium uptake and left ventricular function in aged heartscAMP level modulates scleral collagen remodeling, a critical step in the development of myopiaStimulation of renin secretion by catecholamines is dependent on adenylyl cyclases 5 and 6.Preserved cardiac function despite marked impairment of cAMP generation.A-kinase anchoring proteins: temporal and spatial regulation of intracellular signal transduction in the cardiovascular system.Inhibition of adenylyl cyclase type 5 increases longevity and healthful aging through oxidative stress protectionActivated expression of cardiac adenylyl cyclase 6 reduces dilation and dysfunction of the pressure-overloaded heart.Targeting cardiomyocyte Ca2+ homeostasis in heart failure.Intravenous AAV8 Encoding Urocortin-2 Increases Function of the Failing Heart in Mice.Gene transfer for congestive heart failure: update 2013.Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5.Global comparison of phosphoproteins in human and rodent hearts: implications for translational studies of myosin light chain and troponin phosphorylations.Type 5 adenylyl cyclase increases oxidative stress by transcriptional regulation of manganese superoxide dismutase via the SIRT1/FoxO3a pathway.Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.Cardiac gene therapy: from concept to reality.Molecular mechanisms of sarcomere dysfunction in dilated and hypertrophic cardiomyopathy.Gene therapy for myocardial infarction-associated congestive heart failure: how far have we got?Cardiac-directed expression of a catalytically inactive adenylyl cyclase 6 protects the heart from sustained β-adrenergic stimulation.Principal role of adenylyl cyclase 6 in K⁺ channel regulation and vasodilator signalling in vascular smooth muscle cells.beta(1)-Adrenergic receptor vs adenylyl cyclase 6 expression in cardiac myocytes: differences in transgene localization and intracellular signaling.Function of Adenylyl Cyclase in Heart: the AKAP Connection.Response to Letter to the Editor on "Does Vidarabine Mediate Cardioprotection via Inhibition of AC5?".New Insights in Cardiac β-Adrenergic Signaling During Heart Failure and Aging
P2860
Q26830145-DDB7B18E-1772-470D-AD74-A4A14C436D35Q28590267-266E9A72-8C7B-4C7B-AC42-6B1787E7E379Q30513942-2066BD1C-43C0-4EC8-8404-481324144864Q33851729-14E03A64-F667-485D-8E92-1E307FB66290Q33954281-E1A95288-60CE-490F-B566-CD02263202F1Q34150511-06814158-B27D-4249-B9B5-7C566C0EC291Q34289975-F5D88483-44D2-4D83-B28A-7773A5D7376DQ34700987-228536EE-63C4-4976-AC74-85054BDD4F0AQ34847488-3681FD68-8C95-4E41-A3C5-9C263302A5A6Q34929666-28546C5C-3D05-44CE-B570-0C47E50E0B1DQ34949543-DF36A9E1-67E4-4C3C-9297-872AF1C5AEACQ35019728-C77A3AE7-8DCE-44AA-A875-8973BF2870D3Q35023632-2E99EA24-CA17-432D-A5F3-F7E1C3AB54B2Q35287829-DB903B9D-8B0F-45B0-B4A5-0D21F4545EF3Q35511952-2DAE7539-EBC7-40C7-81E2-CD4098D512C6Q35559287-E85F4C9D-93DE-4E5D-93B7-8A89A0C9CEC2Q35763705-B593D1D7-1F5B-468B-81F0-3DA53CA594EAQ35821871-F11A2D20-2C6D-43B1-8440-FAA499F54B1FQ36698991-CA36E315-BD3F-49F9-A6B8-74935C19D9EBQ36848480-6418AB67-F1E6-4855-B741-73EE2D8D9AABQ37026733-C787CBC3-5C58-41AB-9999-495D909E655BQ37693302-9A3D261A-ABF9-4133-BC76-14067C7244A3Q37847462-19124F5F-0ADE-4DE1-B789-B331367D4CDCQ37965045-2EF771E6-A5B6-48D8-A981-17EA57285C61Q39785961-4E907EB4-671C-491F-A2E6-988513F8C2C5Q40014132-FB253AAA-C1DB-47BE-AA81-4CA29185C1E3Q41212496-9377E5FF-8E41-42C8-AE82-527C2D54EA9CQ41846747-4E601EB1-85E8-465E-9D99-AD2C8911A6B3Q42068044-596A589F-5206-4E49-A2B2-B16696279E1CQ49787381-2DD77EC9-AD1E-4415-921D-46D10317B59CQ51648442-9776E744-2CCC-4D1C-98B8-9D84BA83DBDAQ58790122-D12D27B8-DE0A-48B9-98AC-423AB36FCA81
P2860
Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice.
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@ast
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@en
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@nl
type
label
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@ast
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@en
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@nl
prefLabel
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@ast
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@en
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@nl
P2093
P2860
P1476
Activation of cardiac adenylyl ...... ailing ischemic heart in mice.
@en
P2093
David M Roth
H Kirk Hammond
Mei Hua Gao
Miho Saito
N Chin Lai
Toshiyuki Takahashi
P2860
P304
P356
10.1016/J.JACC.2008.01.015
P407
P577
2008-04-01T00:00:00Z